← Leaderboards
David Armand Fidock
Columbia University Health Sciences
$27,333,547
Attributed
$31,344,579
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,344,579 · 13
By mechanism
R01$23,804,762 · 7
R37$3,883,580 · 1
T32$1,711,641 · 2
P01$1,300,250 · 1
R21$644,346 · 2
Top collaborators
- Filippo Mancia6 shared
- Matthias Quick6 shared
- Dennis E Kyle4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Filippo Mancia$14,879,578
- Matthias Quick$5,155,583
- Laura Marie Hagenah$140,482
- Satish Kumar Dhingra$243,000
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaPlasmodium FalciparumParasitesPharmaceutical PreparationsResistanceDrug ResistanceCombined Modality TherapyMediatingAntimalarialsParasite ResistanceMutationFalciparum MalariaBaseArtemisininsGenesInsightIn VitroMulti-Drug ResistanceBloodMutantAmodiaquineChloroquine ResistanceGeneticAsexual
Grant awards (76)
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$824,925
R01 · FY2025 · AI
Defining the complex genetic basis of Plasmodium falciparum resistance to artemisinin and quinine and identifying resistance-refractory therapeutics$648,982
R01 · FY2025 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$546,798
R37 · FY2025 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum$488,795
R01 · FY2025 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$452,529
R01 · FY2025 · AI · contact PI
Defining the complex genetic basis of Plasmodium falciparum resistance to artemisinin and quinine and identifying resistance-refractory therapeutics$648,448
R01 · FY2024 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$546,798
R37 · FY2024 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum$504,920
R01 · FY2024 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$452,529
R01 · FY2024 · AI · contact PI
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$694,580
R01 · FY2023 · AI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$546,795
R37 · FY2023 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum$491,329
R01 · FY2023 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$452,529
R01 · FY2023 · AI · contact PI
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$694,580
R01 · FY2022 · AI
Defining P. falciparum resistance to artemisinin-based combination therapies$452,529
R01 · FY2022 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$449,100
R37 · FY2022 · AI · contact PI
Deciphering the role of Plasmodium falciparum plasmepsin 2/3 amplifications in mutant pfcrt-driven piperaquine resistance$202,500
R21 · FY2022 · AI · contact PI
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$694,580
R01 · FY2021 · AI
Defining P. falciparum resistance to artemisinin-based combination therapies$452,529
R01 · FY2021 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$449,100
R37 · FY2021 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$197,903
T32 · FY2021 · AI · contact PI
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$694,580
R01 · FY2020 · AI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$449,100
R37 · FY2020 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum$398,264
R01 · FY2020 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$194,983
T32 · FY2020 · AI · contact PI
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria$682,430
R01 · FY2019 · AI
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum$482,788
R01 · FY2019 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$449,100
R37 · FY2019 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum$494,169
R01 · FY2018 · AI · contact PI
Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance$446,789
R37 · FY2018 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$372,726
R01 · FY2018 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$191,208
T32 · FY2018 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum$535,760
R01 · FY2017 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$378,971
R01 · FY2017 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$188,125
T32 · FY2017 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$411,090
R01 · FY2016 · AI · contact PI
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum$397,205
R01 · FY2016 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$187,448
T32 · FY2016 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$535,112
R01 · FY2015 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$400,000
R01 · FY2015 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$185,478
T32 · FY2015 · AI · contact PI
Defining P. falciparum resistance to artemisinin-based combination therapies$446,114
R01 · FY2014 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$400,000
R01 · FY2014 · AI · contact PI
Columbia University Graduate Training Program in Microbiology and Immunology$91,780
T32 · FY2014 · AI · contact PI
Exploiting Fatty Acid Metabolism To Cure Malaria$382,655
R01 · FY2013 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$376,000
R01 · FY2013 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$400,000
R01 · FY2012 · AI · contact PI
Exploiting Fatty Acid Metabolism To Cure Malaria$394,490
R01 · FY2012 · AI · contact PI
Pharmacologic Approaches to Combating Resistance to Antimalarial Combinations$557,200
R01 · FY2011 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$400,000
R01 · FY2011 · AI · contact PI
Exploiting Fatty Acid Metabolism To Cure Malaria$394,490
R01 · FY2011 · AI · contact PI
Pharmacologic Approaches to Combating Resistance to Antimalarial Combinations$581,479
R01 · FY2010 · AI · contact PI
Exploiting Fatty Acid Metabolism To Cure Malaria$398,475
R01 · FY2010 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$375,916
R01 · FY2010 · AI · contact PI
Pharmacologic Approaches to Combating Resistance to Antimalarial Combinations$589,796
R01 · FY2009 · AI · contact PI
Exploiting Fatty Acid Metabolism To Cure Malaria$401,042
R01 · FY2009 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$379,083
R01 · FY2009 · AI · contact PI
A Cell-based HTS for Delayed Death Inhibitors of the Malarial Parasite Plastid$200,521
R21 · FY2009 · NS · contact PI
Pharmacologic Approaches to Combating Resistance to Antimalarial Combinations$579,356
R01 · FY2008 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$378,481
R01 · FY2008 · AI · contact PI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS$247,970
P01 · FY2008 · AI · contact PI
Training Program in Microbiology for Infectious Diseases$237,412
T32 · FY2008 · AI · contact PI
A cell-based HTS for delayed death inhibitors of the malarial parasite plastid$40,075
R21 · FY2008 · NS · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$385,225
R01 · FY2007 · AI · contact PI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS$252,773
P01 · FY2007 · AI · contact PI
Training Program in Microbiology for Infectious Diseases$237,304
T32 · FY2007 · AI · contact PI
A cell-based HTS for delayed death inhibitors of the malarial parasite plastid$201,250
R21 · FY2007 · NS · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$415,000
R01 · FY2006 · AI · contact PI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS$266,587
P01 · FY2006 · AI · contact PI
Role of pfcrt in chloroquine resistance in P. falciparum$375,751
R01 · FY2005 · AI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS$266,587
P01 · FY2005 · AI
Role of pfcrt in chloroquine resistance in P. falciparum$375,751
R01 · FY2004 · AI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS$266,333
P01 · FY2004 · AI
Role of pfcrt in chloroquine resistance in P. falciparum$375,844
R01 · FY2003 · AI
Role of pfcrt in chloroquine resistance in P. falciparum$376,875
R01 · FY2002 · AI
Role of pfcrt in chloroquine resistance in P. falciparum$328,860
R01 · FY2001 · AI